Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1975 Dec;12(6):1281–1289. doi: 10.1128/iai.12.6.1281-1289.1975

Effect of anti-herpesvirus drugs on human and bovine lymphoid function in vitro.

L A Babiuk, B T Rouse
PMCID: PMC415433  PMID: 173654

Abstract

Lymphocyte proliferative responses to phytohemagglutinin, pokeweed mitogen, and herpesvirus (herpes simplex virus and infectious bovine rhinotracheitis virus) antigens were evaluated in the presence of various concentrations of the anti-herpesvirus drugs, methylmethoxydeoxyuridine (OCH3CH2UdR), cytosine arabinoside was inhibitory at 25 mug/ml and cytosine arabinoside was inhibitory OCH3CH2UdR per ml, lymphocyte proliferative responses were unaffected and were not abolished even by concentrations of 2,500 mug/ml. In contrast, adenine arabinocide was inhibitory at 25 mug/ml and cytosine was inhibitory at 5 mug/ml. Both direct and antibody-dependent lymphocyte cytotoxicity of herpesvirus-infected target cells were highly resistant to OCH3CH2UdR; concentrations of 1,000 mug/ml were only marginally inhibitory. The anti-herpesvirus activity of all three drugs is similar (0.5 to 8 mug/ml) (L.A. Babiuk, B. Meldrum, V.S. Gupta, and B. T. Rouse, submitted for publication). The drug OCH3CH2UdR should be given a careful, well-controlled evaluation of its effectiveness in the treatment of herpes simplex infections in animals, perhaps including humans, since our results using in vitro models show that cellular responses important for recovery from herpesvirus infections are unaffected by doses far in excess of those found be be antiviral.

Full text

PDF
1281

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C. Interactions of antibodies, complement components and various cell types in immunity against viruses and pyogenic bacteria. Transplant Rev. 1974;19(0):3–55. doi: 10.1111/j.1600-065x.1974.tb00127.x. [DOI] [PubMed] [Google Scholar]
  2. Buskirk H. H., Crim J. A., Petering H. G., Merritt K., Johnson A. G. Effect of uracil mustard and several antitumor drugs on the primary antibody response in rats and mice. J Natl Cancer Inst. 1965 Jun;34(6):747–758. [PubMed] [Google Scholar]
  3. Byrd W. J., Von Boehmer H., Rouse B. T. The role of the thymus in maturational development of phytohemagglutinin and pokeweed mitogen responsiveness. Cell Immunol. 1973 Jan;6(1):12–24. doi: 10.1016/0008-8749(73)90002-6. [DOI] [PubMed] [Google Scholar]
  4. Ch'ien L. T., Cannon N. J., Charamella L. J., Dismukes W. E., Whitley R. J., Buchanan R. A., Alford C. A., Jr Effect of adenine arabinoside on severe Herpesvirus hominis infections in man. J Infect Dis. 1973 Nov;128(5):658–663. doi: 10.1093/infdis/128.5.658. [DOI] [PubMed] [Google Scholar]
  5. Dickmeiss E. Comparative study of antibody-dependent and direct lymphocyte-mediated cytotoxicity in vitro after alloimmunization in the human. II. Chemical inhibitors. Scand J Immunol. 1974;3(6):817–821. doi: 10.1111/j.1365-3083.1974.tb01317.x. [DOI] [PubMed] [Google Scholar]
  6. Gray G. D., Nichol F. R., Mickelson M. M., Camiener G. W., Gish D. T., Kelly R. C., Wechter W. J., Moxley T. E., Neil G. L. Immunosuppressive, antiviral and antitumor activities of cytarabine derivatives. Biochem Pharmacol. 1972 Feb 15;21(4):465–475. doi: 10.1016/0006-2952(72)90319-x. [DOI] [PubMed] [Google Scholar]
  7. Greenberg A. H., Hudson L., Shen L., Roitt I. M. Antibody-dependent cell-mediated cytotoxicity due to a "null" lymphoid cell. Nat New Biol. 1973 Mar 28;242(117):111–113. doi: 10.1038/newbio242111a0. [DOI] [PubMed] [Google Scholar]
  8. Henney C. S. On the mechanism of T-cell mediated cytolysis. Transplant Rev. 1973;17(0):37–70. doi: 10.1111/j.1600-065x.1973.tb00123.x. [DOI] [PubMed] [Google Scholar]
  9. Janossy G., Greaves M. F. Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. Clin Exp Immunol. 1971 Oct;9(4):483–498. [PMC free article] [PubMed] [Google Scholar]
  10. Jondal M., Wigzell H., Aiuti F. Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. Transplant Rev. 1973;16:163–195. doi: 10.1111/j.1600-065x.1973.tb00120.x. [DOI] [PubMed] [Google Scholar]
  11. Meldrum J. B., Gupta V. S., Saunders J. R. Cell culture studies on the antiviral activity of ether derivatives of 5-hydroxymethyldeoxyuridine. Antimicrob Agents Chemother. 1974 Oct;6(4):393–396. doi: 10.1128/aac.6.4.393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Notkins A. L. Immune mechanisms by which the spread of viral infections is stopped. Cell Immunol. 1974 Mar 30;11(1-3):478–483. doi: 10.1016/0008-8749(74)90045-8. [DOI] [PubMed] [Google Scholar]
  13. Percy D. H., Albert D. M. Developmental defects in mice and rats treated postnatally with cytosine arabinoside. Exp Mol Pathol. 1974 Dec;21(3):381–397. doi: 10.1016/0014-4800(74)90104-x. [DOI] [PubMed] [Google Scholar]
  14. Percy D. H., Albert D. M. Developmental defects in rats treated postnatally with 5-iododeoxyuridine (IUDR). Teratology. 1974 Jun;9(3):275–286. doi: 10.1002/tera.1420090307. [DOI] [PubMed] [Google Scholar]
  15. Prusoff W. H., Goz B. Potential mechanisms of action of antiviral agents. Fed Proc. 1973 Jun;32(6):1679–1687. [PubMed] [Google Scholar]
  16. Rouse B. T., Babiuk L. A. Host defense mechanisms against infectious bovine rhinotracheitis virus. II. Inhibition of viral plaque formation by immune peripheral blood lymphocytes. Cell Immunol. 1975 May;17(1):43–56. doi: 10.1016/s0008-8749(75)80005-0. [DOI] [PubMed] [Google Scholar]
  17. Rouse B. T., Babiuk L. A. Host defense mechanisms against infectious bovine rhinotracheitis virus: in vitro stimulation of sensitized lymphocytes by virus antigen. Infect Immun. 1974 Oct;10(4):681–687. doi: 10.1128/iai.10.4.681-687.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rouse B. T., Babiuk L. A. Host responses to infectious bovine rhinotracheitis virus. III. Isolation and immunologic activities of bovine T lymphocytes. J Immunol. 1974 Nov;113(5):1391–1398. [PubMed] [Google Scholar]
  19. Steele R. W., Chapa I. A., Vincent M. M., Hensen S. A., Keeney R. E. Effects of adenine arabinoside on cellular immune mechanisms in humans. Antimicrob Agents Chemother. 1975 Feb;7(2):203–207. doi: 10.1128/aac.7.2.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stevens D. A., Jordan G. W., Waddell T. F., Merigan T. C. Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial. N Engl J Med. 1973 Oct 25;289(17):873–878. doi: 10.1056/NEJM197310252891701. [DOI] [PubMed] [Google Scholar]
  21. Weinstein L., Chang T. W. The chemotherapy of viral infections. N Engl J Med. 1973 Oct 4;289(14):725–730. doi: 10.1056/NEJM197310042891405. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES